Wasserman, David

Four ethical priorities for neurotechnologies and AI

Yuste, R., Goering, S., Arcas, B. A. Y., Bi, G., Carmena, J. M., Carter, A., Fins, J. J., Friesen, P., Gallant, J., Huggins, J. E., et al. (2017) · Nature

Neuroethics, Human Enhancement, Biomedical InnovationsEthics and Social Impacts of AI

Cited by 678

Resource Limitation and “Forced Irremediability” in Physician-Assisted Deaths for Nonterminal Mental and Physical Conditions: A Survey of the US Public

Berens, N., Wasserman, D., Wakim, P., Bernhard, T., & Kim, S. Y. H. (2022) · Journal of the Academy of Consultation-Liaison Psychiatry

Palliative Care and End-of-Life IssuesPalliative and Oncologic Care

Cited by 11

Neurodiversity, Autism, and Psychiatric Disability: The Harmful Dysfunction Perspective

Wakefield, J. C., Wasserman, D., & Conrad, J. A. (2020) · The Oxford Handbook of Philosophy and Disability

Mental Health and PsychiatryDisability Rights and Representation

Cited by 6